Fukagawa M - Search Results

1

First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties.

Kazama JJ, Koiwa F, Yokoyama K, Fukagawa M, Asano K, Honda D, Akizawa T. Kazama JJ, et al. Among authors: fukagawa m. Clin Pharmacokinet. 2022 Sep;61(9):1271-1284. doi: 10.1007/s40262-022-01139-w. Epub 2022 Jun 28. Clin Pharmacokinet. 2022. PMID: 35763247 Free PMC article. Clinical Trial.

2

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure.

Kazama JJ, Shigematsu T, Yano K, Tsuda E, Miura M, Iwasaki Y, Kawaguchi Y, Gejyo F, Kurokawa K, Fukagawa M. Kazama JJ, et al. Among authors: fukagawa m. Am J Kidney Dis. 2002 Mar;39(3):525-32. doi: 10.1053/ajkd.2002.31402. Am J Kidney Dis. 2002. PMID: 11877571

3

The negative Ca(2+) balance is involved in the stimulation of PTH secretion.

Yokoyama K, Kagami S, Ohkido I, Kato N, Yamamoto H, Shigematsu T, Nakayama M, Fukagawa M, Kawaguchi Y, Hosoya T. Yokoyama K, et al. Among authors: fukagawa m. Nephron. 2002 Sep;92(1):86-90. doi: 10.1159/000064484. Nephron. 2002. PMID: 12187089

4

Management of patients with advanced secondary hyperparathyroidism: the Japanese approach.

Fukagawa M, Kazama JJ, Shigematsu T. Fukagawa M, et al. Nephrol Dial Transplant. 2002 Sep;17(9):1553-7. doi: 10.1093/ndt/17.9.1553. Nephrol Dial Transplant. 2002. PMID: 12198204 Review. No abstract available.

5

Renal osteodystrophy and secondary hyperparathyroidism.

Fukagawa M, Kazama JJ, Kurokawa K. Fukagawa M, et al. Nephrol Dial Transplant. 2002;17 Suppl 10:2-5. doi: 10.1093/ndt/17.suppl_10.2. Nephrol Dial Transplant. 2002. PMID: 12386262 Review.

6

Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients.

Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kakuta T, Onoda N, Koiwa F, Yumita S, Kurokawa K; Japanese Society for Parathyroid Intervention. Fukagawa M, et al. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii31-3. doi: 10.1093/ndt/gfg1008. Nephrol Dial Transplant. 2003. PMID: 12771296

7

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker.

Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T. Tanno Y, et al. Among authors: fukagawa m. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii97-8. doi: 10.1093/ndt/gfg1025. Nephrol Dial Transplant. 2003. PMID: 12771313

8

Circulating 1-84 PTH and large C-terminal PTH fragment levels in uremia.

Kazama JJ, Omori T, Ei I, Ei K, Oda M, Maruyama H, Narita I, Gejyo F, Shigematsu T, Fukagawa M. Kazama JJ, et al. Among authors: fukagawa m. Clin Exp Nephrol. 2003 Jun;7(2):144-9. doi: 10.1007/s10157-003-0226-2. Clin Exp Nephrol. 2003. PMID: 14586733

9

Skeletal resistance to parathyroid hormone as a background abnormality in uremia.

Fukagawa M, Iwasaki Y, Kazama JJ. Fukagawa M, et al. Nephrology (Carlton). 2003 Oct;8 Suppl:S50-2. doi: 10.1046/j.1440-1797.8.s.7.x. Nephrology (Carlton). 2003. PMID: 15012692 Review.

10

Extracorporeal albumin dialysis.

Abe T, Shono M, Kodama T, Kita Y, Fukagawa M, Akizawa T. Abe T, et al. Among authors: fukagawa m. Ther Apher Dial. 2004 Jun;8(3):217-22. doi: 10.1111/j.1526-0968.2004.00148.x. Ther Apher Dial. 2004. PMID: 15154874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

615 results

Search Page